CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- ScaleMarket cap is $2.72B, above the global median of $1.15B
- PositionReturn on equity is -164%, lower than 95% of its Medical Devices peers (median 2.8%)
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.72BUSDvs all stocks (USD)
Revenue (TTM)
229.58MUSDvs all stocks (USD)
Profit Margin
-19.05%vs Medical Devices peers
Beta
1.07xvs all stocks
52-Week Change
117.33%vs all stocks
Market Capitalization
2.72BUSDvs all stocks (USD)
Enterprise Value
2.86BUSDvs all stocks (USD)
Price to Sales (TTM)
11.83xvs Medical Devices peers
Price to Book (MRQ)
183.50xvs Medical Devices peers
Enterprise to Revenue
12.47xvs Medical Devices peers
Enterprise to EBITDA
-151.74xvs Medical Devices peers
Gross Margin
70.70%vs Medical Devices peers
Profit Margin
-19.05%vs Medical Devices peers
Operating Margin
-10.87%vs Medical Devices peers
Return on Assets (TTM)
-5.22%vs Medical Devices peers
Return on Equity (TTM)
-164.01%vs Medical Devices peers
Revenue (TTM)
229.58MUSDvs all stocks (USD)
Revenue per Share (TTM)
7.72USDUpdated Jul 18, 2026Quarterly Revenue Growth
44.70%vs Medical Devices peers
Gross Profit (TTM)
160.84MUSDvs all stocks (USD)
EBITDA (TTM)
-18.87MUSDvs all stocks (USD)
Net Income (TTM)
-43.74MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
44.71%vs Medical Devices peers
Operating Cash Flow (TTM)
-34.48MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
-27.83MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Jul 18, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Medical Devices peers
Revenue
211.08MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
64.77MUSDFY2025 · Dec 31, 2025Gross Profit
146.31MUSDFY2025 · Dec 31, 2025Operating Income
-39.01MUSDvs all stocks (USD)
Pre-tax Income
-58.02MUSDFY2025 · Dec 31, 2025Income Tax Expense
-6.96MUSDFY2025 · Dec 31, 2025Net Income
-51.06MUSDFY2025 · Dec 31, 2025EBIT
-32.77MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
-22.29MUSDFY2025 · Dec 31, 2025Research & Development
20.25MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
165.07MUSDFY2025 · Dec 31, 2025Non-operating Interest Income
423.00KUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
25.26MUSDFY2025 · Dec 31, 2025EPS (Basic)
-1.72USDFY2025 · Dec 31, 2025EPS (Diluted)
-1.72USDFY2025 · Dec 31, 2025Basic Shares Outstanding
29.62MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
29.62MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-51.06MUSDFY2025 · Dec 31, 2025Operating Cash Flow
-50.78MUSDFY2025 · Dec 31, 2025Free Cash Flow
-56.83MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
75.57MUSDFY2025 · Dec 31, 2025Income Tax Paid
420.00KUSDFY2025 · Dec 31, 2025Interest Paid
20.54MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-51.06MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
10.47MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
-9.13MUSDFY2025 · Dec 31, 2025Stock-based Compensation
11.82MUSDFY2025 · Dec 31, 2025Other Non-cash Items
3.99MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-11.47MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
-2.30MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-3.10MUSDFY2025 · Dec 31, 2025Capital Expenditures
-6.05MUSDFY2025 · Dec 31, 2025Net Intangibles (CF)
-672.00KUSDFY2025 · Dec 31, 2025Net Acquisitions
-307.00KUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-6.36MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
24.50MUSDFY2025 · Dec 31, 2025Long-term Debt Payments
-1.02MUSDFY2025 · Dec 31, 2025Net Short-term Debt Issuance
8.98MUSDFY2025 · Dec 31, 2025Other Financing Charges
-637.00KUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
31.83MUSDFY2025 · Dec 31, 2025Shares Outstanding
29.39MSharesUpdated Jul 18, 2026Float Shares
19.63MSharesUpdated Jul 18, 2026Shares Short
4.77MSharesUpdated Jul 18, 2026Short Ratio
5.92daysvs all stocks
Short % of Shares Outstanding
20.31%vs all stocks
% Held by Insiders
10.15%vs all stocks
% Held by Institutions
102.82%vs all stocks
Total Cash (MRQ)
68.10MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
2.31USDUpdated Jul 18, 2026Total Debt (MRQ)
263.96MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
17.86xvs Medical Devices peers
Current Ratio (MRQ)
2.96xvs Medical Devices peers
Book Value per Share (MRQ)
0.5030USDUpdated Jul 18, 2026Total Assets
357.17MUSDvs all stocks (USD)
Total Current Assets
249.94MUSDFY2025 · Dec 31, 2025Total Liabilities
333.62MUSDFY2025 · Dec 31, 2025Total Non-current Assets
107.23MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
251.48MUSDFY2025 · Dec 31, 2025Total Current Liabilities
82.14MUSDFY2025 · Dec 31, 2025Cash
75.57MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
75.57MUSDFY2025 · Dec 31, 2025Accounts Receivable
77.50MUSDFY2025 · Dec 31, 2025Inventory
85.61MUSDFY2025 · Dec 31, 2025Accounts Payable
43.11MUSDFY2025 · Dec 31, 2025Short-term Debt
14.13MUSDFY2025 · Dec 31, 2025Deferred Revenue
1.21MUSDFY2025 · Dec 31, 2025Other Current Liabilities
1.77MUSDFY2025 · Dec 31, 2025Long-term Debt
250.34MUSDFY2025 · Dec 31, 2025Common Stock (Book)
433.38MUSDFY2025 · Dec 31, 2025Retained Earnings
-495.76MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
23.55MUSDvs all stocks (USD)
Treasury Stock
2.85MUSDFY2025 · Dec 31, 202552-Week Low
33.35USDUpdated Jul 18, 202652-Week High
93.12USDUpdated Jul 18, 202652-Week Change
117.33%vs all stocks
Beta
1.07xvs all stocks
50-Day MA
78.72USDUpdated Jul 18, 2026200-Day MA
67.48USDUpdated Jul 18, 2026Avg 10-Day Volume
420.10KSharesUpdated Jul 18, 2026Avg 30-Day Volume
704.48KSharesUpdated Jul 18, 2026Diluted EPS (TTM)
-1.47USDUpdated Jul 18, 2026Other Income / Expense
5.82MUSDFY2025 · Dec 31, 2025Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Return on equity is -164%, lower than 95% of its Medical Devices peers (median 2.8%)Significant
Return on equity: -1.64Industry median: 0.03Industry P5: -0.90Peers compared: 59.00
Debt-to-equity is 17.86×, higher than 95% of its Medical Devices peers (median 0.21×)Significant
Debt-to-equity: 17.86Industry median: 0.21Industry P95: 3.06Peers compared: 59.00
Price-to-book is 183.5×, higher than 95% of its Medical Devices peers (median 3.08×)Significant
Price-to-book: 183.499Industry median: 3.08Industry P95: 15.43Peers compared: 59.00
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.71Profit Margin: -0.19
Financial Health
Altman Z-Score 3.81: safe zoneNotable
Altman Z-Score: 3.81
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Scale
Market cap is $2.72B, above the global median of $1.15BNotable
Market cap (USD): 2,724,665,506Global Median: 1,146,734,693.424
Companies that share the same coordination system — how they create, deliver, or capture value.
Double Medical Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Trevi Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Ligachem Biosciences Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Vera Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
uniQure N.V.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Celldex Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Maravai Lifesciences Holdings Inc.
Tier 1ProductionApproval-Gated PipelineRule
Kodiak Sciences Inc.
Tier 1ProductionApproval-Gated PipelineRule
Supernus Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
AtaiBeckley Inc.
Tier 1ProductionApproval-Gated PipelineRule